Company: SMNR
Filing Date: 2025-07-23
Form Type: CORRESP
Source: 0001193125-25-163409
Chunk: 1

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-07-23
Form: CORRESP
Chunk 1
---
 and Exchange Commission July 23, 2025 Please do not hesitate to contact Michael Blankenship of Winston & Strawn LLP at (713) 651-2678with any questions or comments regarding this letter.

| Sincerely, |     |                         |
| By:        |     | /s/ Lei Huang           |
|            |     | Lei Huang               |
|            |     | Chief Executive Officer |

| cc: | Michael Blankenship, Winston & Strawn LLP |

Jeff Hartlin, Paul Hastings LLP Elizabeth Razzano, Paul Hastings LLP Jaisim Shah, Chief Executive Officer and President, Semnur Pharmaceuticals, Inc. 2